Friday 6 November 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024.

Revenue: +11.9%
EPS: −39.2%
Free cash flow: −52.1%

Quarter to September 2026, against a year earlier

547.43 4.93 +0.91%

Follow VRTX

Alert me

Market cap: $137.5B
P/E: 34.6×
Fwd P/E: 33.2×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Vertex Pharmaceuticals Incorporated (VRTX) Book value per share

Alert me on Book value per share

Vertex Pharmaceuticals Incorporated's book value per share at the end of fiscal 2025 was 73.0×, up 14.7% from 63.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 82.5×. Over the past ten years it has ranged from 4.5× (fiscal 2015) to 73.0× (fiscal 2025) — the current reading is the highest in ten years. Vertex Pharmaceuticals Incorporated ranks 7th of 611 Biotechnology companies by book value per share.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VRTX/book-value-per-share" width="100%" height="360" style="border:0" loading="lazy" title="Vertex Pharmaceuticals Incorporated book value per share, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VRTX/metrics/book-value-per-share">Vertex Pharmaceuticals Incorporated (VRTX) book value per share — stockrow.com</a></p>

Period	Book value per share	Change
FY2025	73.0×	14.73%
FY2024	63.6×	(6.73%)
FY2023	68.2×	25.58%
FY2022	54.3×	38.61%
FY2021	39.2×	17.22%
FY2020	33.4×	41.05%
FY2019	23.7×	35.92%
FY2018	17.4×	112.53%
FY2017	8.2×	50.06%
FY2016	5.5×	20.68%

Period	Book value per share	Change
Sep 2026	82.5×	3.34%
Jun 2026	79.8×	4.74%
Mar 2026	76.2×	4.38%
Dec 2025	73.0×	7.74%
43 more quarters	Free account

Against its own ten years

Low 4.5× High 73.0×

Ten-year median 33.4×

Current reading's percentile 100

Company	Book value per share
REGN Regeneron Pharmaceuticals, Inc. compare	329×
VRTX Vertex Pharmaceuticals Incorporated	82.5×
RPRX Royalty Pharma PLC compare	22.0×
MRNA Moderna, Inc. compare	17.0×
RVMD Revolution Medicines, Inc. compare	11.2×
GMAB Genmab A/S Sponsored ADR compare	9.7×
ROIV Roivant Sciences Ltd. compare	6.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	0.0×
ARGX argenex SE compare	0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

Vertex Pharmaceuticals Incorporated (VRTX) Book value per share

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on VRTX

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on VRTX

Stockrow Weekly